{"id":"https://openalex.org/W2985649499","doi":"https://doi.org/10.1182/blood-2019-131359","title":"System-Level Disease-Driven Immune Signatures in Patients with Diffuse Large B-Cell Lymphoma Associated with Poor Survival","display_name":"System-Level Disease-Driven Immune Signatures in Patients with Diffuse Large B-Cell Lymphoma Associated with Poor Survival","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2985649499","doi":"https://doi.org/10.1182/blood-2019-131359","mag":"2985649499"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-131359","doi":"https://doi.org/10.1182/blood-2019-131359","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131359","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088935415","display_name":"Astrid Tschan\u2010Plessl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Astrid Tschan-Plessl","raw_affiliation_strings":["University Hospital of Basel, Basel, CHE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Basel, Basel, CHE","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082782805","display_name":"Eivind Heggernes Ask","orcid":"https://orcid.org/0000-0001-8655-1433","observed_orcids":["https://orcid.org/0000-0001-8655-1433"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Eivind Heggernes Ask","raw_affiliation_strings":["Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041293648","display_name":"Thea Johanne Gjerdingen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Thea Johanne Gjerdingen","raw_affiliation_strings":["Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027175862","display_name":"Michelle S\u00e6tersmoen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Michelle Saetersmoen","raw_affiliation_strings":["Oslo University Hospital, Oslo, NOR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Oslo, NOR","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021412783","display_name":"Hanna Julie Hoel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Hanna Julie Hoel","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004342251","display_name":"Merete Thune Wiiger","orcid":"https://orcid.org/0000-0003-4833-3237","observed_orcids":["https://orcid.org/0000-0003-4833-3237"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Merete Thune Wiiger","raw_affiliation_strings":["Department of Cancer Immunology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028004266","display_name":"Johanna Olweus","orcid":"https://orcid.org/0000-0002-1898-3100","observed_orcids":["https://orcid.org/0000-0002-1898-3100"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Johanna Olweus","raw_affiliation_strings":["Oslo University Hospital, Oslo, NOR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Oslo, NOR","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072124785","display_name":"Bjo\u0308rn Engelbrekt Wahlin","orcid":"https://orcid.org/0000-0003-3566-8847","observed_orcids":["https://orcid.org/0000-0003-3566-8847"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn E Wahlin","raw_affiliation_strings":["Center of Hematology, Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Hematology, Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083361833","display_name":"Amir Horowitz","orcid":"https://orcid.org/0000-0003-3100-2810","observed_orcids":["https://orcid.org/0000-0003-3100-2810","https://orcid.org/0000-0003-4602-1440"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir Horowitz","raw_affiliation_strings":["Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016323798","display_name":"Todd A. Fehniger","orcid":"https://orcid.org/0000-0002-8705-2887","observed_orcids":["https://orcid.org/0000-0002-8705-2887"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd A Fehniger","raw_affiliation_strings":["Department of Medicine, Washington University School of Medicine, Saint Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Washington University School of Medicine, Saint Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088720489","display_name":"Harald Holte","orcid":"https://orcid.org/0000-0001-9799-9428","observed_orcids":["https://orcid.org/0000-0001-9799-9428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harald Holte","raw_affiliation_strings":["Norwegian Cancer Genomics Consortium, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian Cancer Genomics Consortium, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090605318","display_name":"Arne Kolstad","orcid":"https://orcid.org/0000-0003-2699-3357","observed_orcids":["https://orcid.org/0000-0003-2699-3357"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Arne Kolstad","raw_affiliation_strings":["Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061606756","display_name":"Karl\u2010Johan Malmberg","orcid":"https://orcid.org/0000-0002-8718-9373","observed_orcids":["https://orcid.org/0000-0002-8718-9373"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Karl-Johan Malmberg","raw_affiliation_strings":["Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"2897","last_page":"2897"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.781000018119812},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8769999742507935},{"id":"https://openalex.org/keywords/t-cell-differentiation","display_name":"T cell differentiation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/serum-protein-profiling","display_name":"serum protein profiling","score":0.7080000042915344},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cd70","display_name":"CD70","score":0.8069999814033508},{"id":"https://openalex.org/keywords/il-18","display_name":"IL-18","score":0.9020000100135803},{"id":"https://openalex.org/keywords/gzma","display_name":"granzyme A","score":0.9449999928474426},{"id":"https://openalex.org/keywords/cd83","display_name":"CD83","score":0.8500000238418579},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6949999928474426},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7002802491188049},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5020315647125244},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.5008351802825928},{"id":"https://openalex.org/C2778015335","wikidata":"https://www.wikidata.org/wiki/Q17051163","display_name":"Mass cytometry","level":4,"score":0.4942000210285187},{"id":"https://openalex.org/C2780380082","wikidata":"https://www.wikidata.org/wiki/Q12646460","display_name":"Granzyme B","level":4,"score":0.49357807636260986},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4895356595516205},{"id":"https://openalex.org/C183193105","wikidata":"https://www.wikidata.org/wiki/Q425068","display_name":"Granzyme","level":5,"score":0.4672650694847107},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.46068763732910156},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.4577871561050415},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4469704031944275},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.410582035779953},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.37681931257247925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3356825113296509},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32064491510391235},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2960051894187927},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.23924395442008972},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.21011251211166382},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.18603774905204773},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14153185486793518},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2776062744","wikidata":"https://www.wikidata.org/wiki/Q21103279","display_name":"Perforin","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-131359","doi":"https://doi.org/10.1182/blood-2019-131359","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131359","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"No poverty","score":0.6299999952316284,"id":"https://metadata.un.org/sdg/1"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4312061069","https://openalex.org/W2062137773","https://openalex.org/W150405246","https://openalex.org/W1507634793","https://openalex.org/W2015696797","https://openalex.org/W3029481696","https://openalex.org/W2018932831","https://openalex.org/W2082517037","https://openalex.org/W2317516000","https://openalex.org/W1971813119"],"abstract_inverted_index":{"Global":[0],"gene":[1],"expression":[2,113,146,218],"profiling":[3,63],"of":[4,43,91,127,134,147,164,219,235,243,284,292,309,318,328,354,365,372,446,479,509,532],"the":[5,22,39,180,239,329,348,355,380],"tumor":[6],"microenvironment":[7],"in":[8,64,72,110,119,168,238,254,270,276,297,325,340,350,376,431,449,453],"diffuse":[9],"large":[10,41],"B-cell":[11],"lymphoma":[12,79],"(DLBCL)":[13],"has":[14],"revealed":[15,177],"broad":[16],"innate":[17],"immune":[18,70,129,183,241,264,436],"signatures":[19,184,265,437],"that":[20,45,178,179,203,246,335,451,459],"distinguish":[21],"heterogeneous":[23],"disease":[24,302],"subtypes":[25],"and":[26,51,61,80,82,143,153,159,173,193,228,252,303,313,323,360,379,414,485],"correlate":[27],"with":[28,75,100,105,132,249,267,433],"good":[29],"treatment":[30],"outcome.":[31],"However,":[32],"we":[33,57],"still":[34],"lack":[35],"tools":[36],"to":[37,48,68,115,187,259,279,343,439,457],"identify":[38],"relatively":[40],"group":[42],"patients":[44,74,95,104,205,213,245,255,277,285,311,324,341,359,432,450],"are":[46,247,257,336],"refractory":[47,258],"initial":[49],"therapy":[50],"have":[52],"a":[53,65,106,123],"dismal":[54],"prognosis.":[55],"Here,":[56],"used":[58],"mass":[59,403],"cytometry":[60],"serum":[62,165,208,274,293,447],"systems-level":[66],"approach":[67],"analyze":[69],"responses":[71],"36":[73],"aggressive":[76],"B":[77,304],"cell":[78,130,141,333],"age-":[81],"sex-matched":[83],"healthy":[84,116,280,321,344,361,377],"controls.":[85,117,281,362],"Stochastic":[86],"neighbor":[87],"embedding":[88],"(t-SNE)":[89],"analysis":[90,163,291],"protein":[92,112,166,209],"profiles":[93,167,275],"divided":[94],"into":[96],"two":[97,169,381],"distinct":[98,233],"clusters,":[99],"cluster":[101,120,298,440],"2":[102,121,299],"representing":[103],"more":[107,124],"severe":[108],"deviation":[109],"their":[111,128,207],"compared":[114,278,342,456],"Patients":[118,296],"showed":[122,202],"dramatic":[125],"perturbation":[126],"repertoires":[131],"expansion":[133],"myeloid-derived":[135,367],"suppressor":[136,368],"cells":[137,319,369,375,409],"(MDSCs),":[138],"increased":[139],"T":[140],"differentiation":[142],"significantly":[144],"higher":[145,215],"metabolic":[148],"markers":[149,412],"such":[150],"as":[151,370,401],"GLUT-1":[152],"activation":[154],"markers,":[155],"including":[156,222],"Ki67,":[157],"CD38":[158],"PD-1.":[160],"An":[161],"extended":[162],"independent":[170],"cohorts":[171],"(n=69":[172],"n=80":[174],"patients,":[175],"respectively)":[176],"identified":[181,287],"systemic":[182,240],"were":[185,286],"linked":[186],"poor":[188,250,268],"progression":[189],"free":[190],"survival":[191,196,251,430],"(PFS)":[192],"inferior":[194],"overall":[195],"(OS).":[197],"Immune":[198],"monitoring":[199],"during":[200],"chemo-immunotherapy":[201],"most":[204],"normalized":[206],"profiles.":[210,294],"Notably,":[211],"non-responding":[212],"retained":[214],"than":[216],"normal":[217],"several":[220],"proteins,":[221],"PD-L1,":[223],"CD70,":[224],"IL-18,":[225],"granzyme":[226],"A":[227],"CD83.":[229],"These":[230],"studies":[231],"demonstrate":[232],"patterns":[234],"disease-driven":[236],"alterations":[237],"response":[242],"DLBCL":[244],"associated":[248,266],"persist":[253],"who":[256],"therapy.":[260],"Figure":[261,463],"1":[262,441,464],"System-level":[263],"prognosis":[269],"DLBCL.":[271],"A)":[272],"Altered":[273],"Two":[282],"clusters":[283,399],"based":[288],"on":[289,475,505,528],"t-SNE":[290,307,330,356],"B)":[295],"had":[300],"bulky":[301],"symptoms.":[305],"C)":[306],"map":[308],"all":[310,326,373],"(n=36)":[312],"controls":[314,322],"(n=17).":[315],"Relative":[316],"abundance":[317],"from":[320],"areas":[327],"clustering,":[331],"highlighting":[332],"subsets":[334],"larger":[337],"or":[338,406,442,481,511,534],"smaller":[339],"donors.":[345],"Colors":[346],"indicate":[347],"difference":[349],"kernel":[351],"density":[352],"estimation":[353],"data":[357],"for":[358,410],"D)":[363],"Abundance":[364,445],"monocytic":[366],"percentage":[371],"CD45+":[374],"donors":[378],"patient":[382,398],"clusters.":[383],"White,":[384,419],"Healthy":[385,420],"controls;":[386,421],"Blue,":[387,422],"Cluster":[388,391,423,426],"1;":[389,424],"Red,":[390,425],"2.":[392,427,443],"E)":[393],"Major":[394],"phenotypic":[395],"differences":[396],"between":[397],"shown":[400],"mean":[402],"intensity":[404],"(MMI)":[405],"percent":[407],"positive":[408],"selected":[411],"(CD38":[413],"PD-1)":[415],"across":[416],"multiple":[417],"subsets.":[418],"F-G)":[428],"Overall":[429],"serologically":[434],"defined":[435],"belonging":[438],"H)":[444],"proteins":[448],"stayed":[452],"remission":[454],"(n=24)":[455],"those":[458],"did":[460],"not":[461],"(n=6).":[462],"Disclosures":[465],"Olweus:":[466],"Gilead":[467],"Kite:":[468],"Research":[469,514,517,523],"Funding;":[470,515,524],"Intellia:":[471],"Consultancy,":[472,522,526],"Honoraria,":[473,498],"Membership":[474,504,527],"an":[476,506,529],"entity's":[477,507,530],"Board":[478,508,531],"Directors":[480,510,533],"advisory":[482,512,535],"committees.":[483,536],"Wahlin:Roche":[484],"Gilead:":[486],"Consultancy.":[487],"Fehniger:Cyto-Sen":[488],"Therapeutics:":[489],"Consultancy;":[490],"Horizon":[491],"Pharma":[492],"PLC:":[493],"Other:":[494,499],"Consultancy":[495],"(Spouse).":[496],"Holte:Novartis:":[497],"Advisory":[500],"board.":[501],"Kolstad:Nordic":[502],"Nanovector:":[503],"committees,":[513],"Merck:":[516],"Funding.":[518],"Malmberg:Fate":[519],"Therapeutics,":[520],"Inc.:":[521],"Vycellix:":[525]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2025-10-10T00:00:00"}